169055 ⎘
Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations ; Physical properties thereof, e.g. dissolubility
SCREENING METHOD
#2MODULAR PROCESS ANALYTICAL TECHNOLOGY TESTING APPARATUS
#3QUANTITATION OF TAMOXIFEN AND METABOLITES THEREOF BY MASS SPECTROMETRY
#4TEXTURED FILM FOR USE IN A DISSOLUTION ADAPTER AND USES THEREOF
#5METHODS FOR VALIDATING MEDICATION
#6NON-ENZYMATIC DEXTROSE SENSORS FOR DIALYSIS
#7MACHINE LEARNING GUIDED ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY FOR CALIBRATION-FREE PHARMACEUTICAL MOISTURE CONTENT MONITORING
#8DEMARCATION TEMPLATE FOR HAZARDOUS CONTAMINANT TESTING
#9Sensitivity Traps for Electronic Trace Detection
#10MIXING SYSTEMS AND METHODS FOR IN-LINE MIXING OF COMPONENTS OF A MEDICAL FLUID
#11APPARATUS AND METHOD FOR APPLYING NORMAL FORCES TO A SUPPORT DEVICE INCLUDING A PERMEABLE MEMBRANE
#12FILTER PRESSING SYSTEM AND FILTER PRESSING METHOD
#13METHODS FOR VALIDATING MEDICATION
#14SYSTEMS AND METHODS FOR DETERMINING ANALYTE CONCENTRATIONS FOR MEDICAMENT DELIVERY DEVICES
#15DETERMINATION OF PARTICULATE CONTAMINANTS IN PARTICLES AND COMPOSITIONS
#16A METHOD AND DEVICE FOR DETERMINING THICKNESS AND SOLID FRACTION OF A PHARMACEUTICAL TABLET USING NON-INVASIVE PROCESS ELECTRICAL TOMOGRAPHY
#17EMULATOR OF SUBCUTANEOUS ABSORPTION AND RELEASE
#18SYSTEMS, METHODS, AND APPARATUSES FOR CHARACTERIZING RELEASE PROFILES FOR LONG-ACTING INJECTABLE MEDICATIONS
#19SYSTEM AND METHOD FOR SPECTROSCOPIC DETERMINATION OF CHEMICAL COMPOSITIONS FROM SAMPLE SCANS
#20INFORMATION PROCESSING METHOD, RECORDING MEDIUM, AND INFORMATION PROCESSING DEVICE
#21ABALOPARATIDE FORMULATIONS AND METHODS OF TESTING, STORING, MODIFYING, AND USING SAME
#22RAMAN ANALYSIS OF PHARMACEUTICAL DOSAGE FORMS
#23METHOD AND COMPOSITION BOTH FOR TREATING OR DIAGNOSING INFLAMMATORY BOWEL DISEASE (IBD)
#24MODULAR PROCESS ANALYTICAL TECHNOLOGY TESTING APPARATUS
#25QUALITY INSPECTION APPARATUS, QUALITY INSPECTION METHOD, AND STORAGE MEDIUM
#26RAMAN ANALYSIS OF PHARMACEUTICAL DOSAGE FORMS
#27PHARMACEUTICAL PACKAGES AND METHODS OF REDUCING FORMATION OF N-NITROSODIMETHYLAMINE
#28A MEASURING APPARATUS FOR INLINE MEASURING THE HOMOGENIZING DEGREE OF A FLUID PRODUCT IN A DISPERSING UNIT
#29METHOD FOR QUANTIFYING REACTIVE NOX, AND FORMULATION FOR SUPPRESSING GENERATION OF NITROSO COMPOUNDS
#30ABALOPARATIDE FORMULATIONS AND METHODS OF TESTING, STORING, MODIFYING, AND USING SAME
#31DRUG PRODUCT SURROGATE SOLUTIONS
#32ARTIFICIAL LYOPHILIZED PRODUCT SAMPLES FOR AUTOMATED VISUAL INSPECTION SYSTEMS
#33METHOD FOR EVALUATING ECOLOGICAL EFFECTS OF ANTIBIOTICS BASED ON BACTERIAL-ARCHAEAL-FUNGAL CO-OCCURRENCE NETWORK
#34CENTRIFUGAL FEEDER AND TABLET INSPECTION DEVICE COMPRISING SAME
#35CENTRIFUGAL FEEDER AND TABLET INSPECTION DEVICE COMPRISING SAME
#363D CAMERAS OR SENSORS INPUTTING TO MULTI-MODAL GENERATIVE ARTIFICIAL INTELLIGENCE MODELS TRAINED ON IMAGES OR VIDEOS
#37Automatic Dissolution Testing System
#38DETECTION OF PHARMACEUTICAL PRODUCT FREEZING HISTORY USING WATER PROTON NMR
#39STIRRING DEVICE FOR STIRRING A BIPHASIC LIQUID
#40METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM BLOOD PRODUCTS
#41DETERMINATION OF THE TRAPPED VOLUME OF A LIPOSOME
#42TERMINAL, BASE STATION, AND METHOD FOR THE SAME
#43METHOD FOR EVALUATING HOMOGENEITY OF ORAL SUSPENSIONS
#44Pharmaceutical Apparatus And Method Of Manufacturing A Patient-Tailored Pharmaceutical Tablet
#45ABALOPARATIDE FORMULATIONS AND METHODS OF TESTING, STORING, MODIFYING, AND USING SAME
#46METHOD FOR ANALYZING ENDOSOMAL ESCAPE EFFICIENCY OF DRUG DELIVERY PARTICLES
#47INDIVIDUALIZED SOLID DOSAGE PRODUCTS AND A SYSTEM AND METHOD FOR THE GLOBALLY INTEGRATED PHARMACEUTICAL MANUFACTURING AND ITS MONITORING THEREOF
#48Wearable device for differential measurement on pulse rate and blood flow
#49DISSOLUTION TEST
#50METHOD OF CHARACTERIZATION OF RELEASE OF POORLY SOLUBLE MATERIALS AND UPTAKE IN COMPLEX LIQUIDS
#51WEARABLE DEVICE FOR DIFFERENTIAL MEASUREMENT ON PULSE RATE AND BLOOD FLOW
#52MEASUREMENTS USING CAMERA SENSOR COUPLED TO A CHEMICAL DETECTION SYSTEM
#53REMOTE SENSING SYSTEM WITH TIME-OF-FLIGHT SENSOR, ACTIVE ILLUMINATOR AND LIGHT SENSING SYSTEM
#54TIME-OF-FLIGHT MEASUREMENT ON USER WITH CAMERAS AND POSITION SENSOR
#55SENOLYTIC DRUG SCREENING METHOD AND SENOLYTIC DRUG
#56MEASUREMENTS USING CAMERA IMAGING TISSUE COMPRISING SKIN OR THE HAND
#57QUANTIFICATION METHOD OF POLYSORBATE IN AQUEOUS FORMULATIONS
#58METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM CULTURED CELLS
#59ACTIVE REMOTE SENSING OF ATMOSPHERIC GASES OR SMOKE USING A TIME-OF-FLIGHT SENSOR
#60ABALOPARATIDE FORMULATIONS AND METHODS OF TESTING, STORING, MODIFYING, AND USING SAME
#61IN VITRO RELEASE ASSAY METHODS FOR LIPOSOMAL AMINOGLYCOSIDE FORMULATIONS
#62Method of Screening Antioxidants
#63DEMARCATION TEMPLATE FOR HAZARDOUS CONTAMINANT TESTING
#64Total extract of Fructus Cnidii and its application and map construction method
#65HIGH-PURITY THIENOPYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR
#66SYSTEMS FOR FACILE VIRAL CLEARANCE VALIDATION THROUGH THE DEVELOPMENT OF FLUORESCENT VIRAL SURROGATES
#67Time-of-flight sensors co-registered with camera systems
#68Devices With Optically Readable Liquid Reservoirs
#69METHODS OF MODELING LIQUID PROTEIN COMPOSITION STABILITY
#70METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS
#71ACTIVATED-QUENCHED POLYSACCHARIDE AND IMPROVED METHODS FOR QUANTIFICATION OF POLYSACCHARIDE IN A VACCINE COMPOSITION
#72METHODS OF IN VITRO DISSOLUTION
#73CAMERA BASED SYSTEM WITH PROCESSING USING ARTIFICIAL INTELLIGENCE FOR DETECTING ANOMALOUS OCCURRENCES AND IMPROVING PERFORMANCE
#74INDICATOR FOR PERISHABLE PRODUCTS
#75Wearable devices comprising semiconductor diode light sources with improved signal-to-noise ratio
#76APPARATUS AND METHOD FOR EVALUATING PHYSICAL STRENGTH OR ROBUSTNESS OF SOLID PHARMACEUTICAL DOSAGE FORMS BASED ON AN IMPACT STRIKE TEST
#77METHODS OF MAKING AND ASSESSING ALLERGENIC TREE NUT COMPOSITIONS
#78RECIPROCAL INJECTION DEVICE AND METHODS OF USING SAME
#79ACTIVATED-QUENCHED POLYSACCHARIDE AND IMPROVED METHODS FOR QUANTIFICATION OF POLYSACCHARIDE IN A VACCINE COMPOSITION
#80CAMERA BASED SYSTEM WITH PROCESSING USING ARTIFICIAL INTELLIGENCE FOR DETECTING ANOMALOUS OCCURRENCES AND IMPROVING PERFORMANCE
#81IMMUNOASSAY-BASED DETERMINATION OF IN-SOLUTION BINDING KINETICS
#82METHOD FOR SELECTING, ASSESSING, OR PRODUCING SODIUM LAURYL SULFATE AS RAW MATERIAL FOR PHARMACEUTICAL FORMULATION, OR FORMULATION OR THE LIKE CONTAINING SAME
#83ADAPTIVE PERFUSION SYSTEMS AND METHODS FOR DRUG RELEASE TESTING
#84RPLC-BASED PEPTIDE MAPPING CHROMATOGRAPHIC PERFORMANCE USING METAL CHELATORS AS MOBILE PHASE ADDITIVES
#85Quantitation of tamoxifen and metabolites thereof by mass spectrometry
#86MARKING INSPECTION DEVICE AND MARKING DEVICE FOR TRANSPARENT EDIBLE OBJECTS
#87PATHOGENIC SUSCEPTIBILITY ASSESSMENT BASED ON AUTOFLUORESENCE
#88GASTROINTESTINAL TRACT SIMULATION SYSTEM AND METHOD
#89CITY POLLUTION ENVIRONMENT SIMULATION APPARATUS
#90LIPOCALIN-TYPE PROSTAGLANDIN D2 SYNTHASE PRODUCTION PROMOTING AGENT
#91Identifying objects using near-infrared sensors, cameras or time-of-flight detectors
#92Temperature Control System for a Diffusion Cell, Diffusion Cell, Diffusion Cell System, and Method for Controlling the Temperature in a Diffusion Cell
#93Compositions Containing a Pharmacophore with Selectivity to Diseased Tissue and Methods of Making Same
#94BLUE LIGHT OXIDATION INHIBITOR AND SCREENING METHOD FOR SAME
#95SYSTEM AND METHOD FOR MEASURING RAPID DECOMPRESSION ICE NUCLEATION IN LYOPHILIZATION
#96DIAGNOSTIC TOOL FOR SCREENING THE IMPACT OF PRODUCT INGREDIENTS FOR UROGENITAL MICROBIOMES THERAPIES
#97Analysis method of 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient, treatment for amyotrophic lateral sclerosis, inhibition of progression of amyotrophic lateral sclerosis, and method of producing medicament containing 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient
#98METHODS OF MEASURING CARFILZOMIB
#99Determination of the supramolecular organization of encapsulated molecules by luminescence lifetime analysis
#100THERAPEUTIC DRUG FOR LIPID-PEROXIDATION-INDUCED DISEASES AND SCREENING METHOD FOR THERAPEUTIC DRUGS FOR LIPID-PEROXIDATION-INDUCED DISEASES
#101Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases
#102MAGNETIC RESONANCE SPECTROSCOPY TO CALIBRATE AND SELECT DOSES, FORMULATIONS, AND DEVICES FOR INTRA-NASAL ADMINISTRATION OF N-ACETYLCYSTEINE
#103SAMPLE ANALYSIS DEVICE, SAMPLE ANALYSIS METHOD, PHARMACEUTICAL ANALYSIS DEVICE AND PHARMACEUTICAL ANALYSIS METHOD
#104SYSTEM AND METHOD FOR MICRODIALYSIS FOR IN-VITRO RELEASE TESTING OF DOSAGE FORMS
#105Raman analysis of pharmaceutical dosage forms
#106DILUENTS, STANDARDIZATION AGENTS AND VISCOSITY CONTROL FOR CANNABINOIDS FORMULATIONS AND METHODS THEREOF
#107Abaloparatide formulations and methods of testing, storing, modifying, and using same
#108Active illumination and time-of-flight camera system to evaluate facial blood flow, eye movements and physiological parameters
#109INTERPRETING AN ELECTROCHEMICAL RESPONSE
#110COMPOSITIONS AND METHODS FOR TREATING G PROTEIN COUPLED RECEPTOR MEDIATED CONDITIONS
#111SPECTRAL ANALYSIS OF A SAMPLE
#112DYNAMIC PROCESS END POINT DETECTION
#113In situ determination of acceptable resuspension in pharmaceutical products using water proton NMR
#114PROPHYLACTIC OR THERAPEUTIC AGENT FOR AT LEAST ONE TYPE OF CANCER SELECTED FROM GROUP CONSISTING OF PANCREATIC CANCER, LUNG CANCER, COLORECTAL CANCER, CHOLANGIOCARCINOMA AND LIVER CANCER, PROPHYLACTIC OR THERAPEUTIC AGENT FOR SAID CANCER WHICH IS USED IN COMBINATION DRUG IN COMBINATION WITH SAID AGENT, COMBINATION DRUG COMPRISING SAID AGENTS, AND METHOD FOR SCREENING FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
#115Short-wave infrared sensor for identifying based on water content
#116In situ, real-time in-line detection of filling errors in pharmaceutical product manufacturing using water proton NMR
#117NUCLEIC ACID CONSTRUCT THAT CAN MEASURE HOMOLOGOUS RECOMBINATION ACTIVITY, AND METHOD FOR USING SAME
#118METHOD FOR SCREENING FOR, METHOD FOR PRODUCING, AND METHOD FOR DESIGNING DRUG ACTIVE INGREDIENTS
#119PEAK AREA DISPLAY DEVICE, PEAK AREA DISPLAY METHOD, PEAK AREA CALCULATION DEVICE AND PEAK AREA CALCULATION METHOD
#120AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF
#121Small angle x-ray scattering methods for characterizing the iron core of iron carbohydrate colloid drug products
#122Quantitation of tamoxifen and metabolites thereof by mass spectrometry
#123DRUG INFUSION DEVICES COMPATIBLE WITH DRUG FORMULATIONS
#124DRUG FORMULATIONS FOR RESERVOIR-BASED DELIVERY
#125NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE
#126Abaloparatide formulations and methods of testing, storing, modifying, and using same
#127HIGH PERFORMANCE LIQUID CHROMATOGRAPHY QUANTIFICATION OF EXCIPIENTS
#128MARKERS FOR PHARMACEUTICALS
#129METHODS OF EVALUATING SMALL MOLECULE-MODIFIED POLYMERS IN COMPOSITIONS
#130SYSTEM FOR DETECTING EXTRACELLULAR PURINERGIC RECEPTOR LIGAND, AND NON-HUMAN ANIMAL HAVING THE SYSTEM INTRODUCED THEREINTO
#131Device and Method for the Analytical and Sensory Determination of the Release of an Active Substance from a Release System
#132In vitro release testing (IVRT) device for orally inhaled drug products
#133ELECTROCHEMICAL AUTHENTICATION METHOD
#134Method for identifying the quality of a liquid pharmaceutical product
#135SAMPLING SYSTEMS AND TECHNIQUES TO COLLECT HAZARDOUS CONTAMINANTS WITH HIGH PICKUP AND SHEDDING EFFICIENCIES
#136BIORELEVANT DISSOLUTION MEDIA
#137BIOLOGICAL MUCOUS MEMBRANE MODEL AND METHOD OF EVALUATING RETENTION OF MUCOUS MEMBRANE PROTECTIVE AGENT
#138SYSTEMS AND APPROACHES FOR DRUG DELIVERY
#139Apparatus and method for monitoring and recording disintegration times for pharmaceutical products
#140Active remote sensing system using time-of-flight sensor combined with cameras and wearable devices
#141SYSTEMS AND METHODS FOR HIGH-THROUGHPUT SCREENING AND ANALYSIS OF DRUG DELIVERY SYSTEMS IN VITRO
#142MIXTURE OF ISOMERS OF AMINAPHTONE, ANALYTICAL METHOD FOR IDENTIFYING THEM AND PHARMACEUTICAL COMPOSITION COMPRISING SAID ISOMERS
#143Use of stable isotopes to prove authentication of manufacturing location
#144Raman analysis of pharmaceutical dosage forms
#145TOTAL ORGANIC CARBON AND CONDUCTIVITY VERIFICATION AND CALIBRATION USING A SINGLE SAMPLE
#146Device for testing solubility of drugs in gastrointestinal tract
#147Three-Dimensional Imaging of a Sample in a Liquid Provision Chamber
#148Analysis method of 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient, treatment for amyotrophic lateral sclerosis, inhibition of progression of amyotrophic lateral sclerosis, and method of producing medicament containing 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient
#149METHOD FOR DETERMINING B VITAMINS AND THEIR VITAMERS
#150Highly purified batches of pharmaceutical grade migalastat and methods of producing the same
#151PATCH DEVICES, METHODS AND APPARATUS FOR FORMING, AND TESTING PHARMACEUTICAL AGENT DELIVERY PATCH DEVICES
#152MESH FOR DISSOLUTION TEST
#153BIORELEVANT COMPOSITION
#154Manufacturing a biologic pharmaceutical using causal models
#155Solids analysis using Raman spectroscopy
#156FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
#157PREDICTING ANIMAL TESTING MEASUREMENT LEVELS
#158SYSTEM AND METHOD FOR CHARACTERIZING DRUG PRODUCT IMPURITIES
#159Detection of pharmaceutical product freezing history using water proton NMR
#160METHODS AND COMPOSITIONS OF CHONDRISOMES
#161Remote sensing and measurement system using time-of-flight detectors
#162Viral clearance evaluation for biological medical product preparation processes
#163Method of testing crystallinity in amorphous pharmaceutical compositions
#164Solid dosage component measurement device and solid dosage component measurement method
#165Hazardous contaminant collection kit and rapid testing
#166ANALYSIS METHOD OF 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE ACTIVE PHARMACEUTICAL INGREDIENT, TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSIS, INHIBITION OF PROGRESSION OF AMYOTROPHIC LATERAL SCLEROSIS, AND METHOD OF PRODUCING MEDICAMENT CONTAINING 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE ACTIVE PHARMACEUTICAL INGREDIENT
#167Feature quantity calculating method, feature quantity calculating program, and feature quantity calculating device, screening method, screening program, and screening device, compound creating method, compound creating program, and compound creating device
#168ANALYTICAL METHOD FOR DETERMINATION OF IN VITRO DRUG RELEASE PROFILE FROM MICRONEEDLE PATCHES
#169Diffusion Cell Clamping and Assembly Tools
#170Application of the apparent volume of distribution in extraction technologies and pharmacokinetics
#171METHODS OF INHIBITING LYSINE-SPECIFIC DEMETHYLASE 1 (LSD-1)
#172Wearable device coupled to time-of-flight imaging system
#173METHODS OF GENERATING ORGANOIDS FOR HIGH THROUGHPUT SCREENING OF DRUGS
#174DISSOLUTION DEVICE
#175FEATURE QUANTITY CALCULATING METHOD, FEATURE QUANTITY CALCULATING PROGRAM, FEATURE QUANTITY CALCULATING DEVICE, SCREENING METHOD, SCREENING PROGRAM, AND COMPOUND CREATING METHOD
#176Sensitivity Traps for Electronic Trace Detection
#177METHOD FOR PRODUCING POLYPEPTIDE HETERO-OLIGOMER
#178Method and device for physicochemical characterization of materials
#179Abaloparatide formulations and methods of testing, storing, modifying, and using same
#180PHARMACEUTICAL FOR PREVENTING AND/OR TREATING STRESS LOAD-RELATED DISEASE
#181APPARATUS AND METHODS FOR THERMALLY TESTING A SAMPLE
#182Diffusion cell with recirculating receptor chamber
#183Screening Method for Client Protein-Protecting Protein, and Physiologically Active Protein-Stabilizing Protein and Pharmaceutical Composition Comprising Said Protein
#184SCREENING METHOD FOR THERAPEUTIC DRUG OR PROPHYLACTIC DRUG FOR TAUOPATHY AND DIAGNOSTIC METHOD FOR TAUOPATHY
#185Detecting Compounds in Airborne Particles Using Ion Exchange
#186Powder identification system and method
#187Artificial intelligence model for predicting actions of test substance in humans
#188METHOD OF ESTABLISHING FINGERPRINT SPECTRUM OF TRADITIONAL CHINESE MEDICINE COMPOSITION WITH EFFECT OF REGULATING DEPRESSION EMOTION OR FORMULATION THEREOF
#189Purified Detomidine, Process of Preparing and Methods of Use
#190METHOD FOR CULTURING CANCER TISSUE OR TISSUE ANALOGOUS TO CANCER TISSUE
#191Pre-filled parenteral drug inspection station and method of using the same
#192Method for determining content of menthol in preparation of traditional Chinese medicine composition
#193IMMOBILIZED ENZYMES AND MICROSOMES ON MAGNETIC SCAFFOLDS
#194PROCESS FOR PREPARING BUFFER SOLUTIONS FOR IN VITRO TESTING OF THE SOLUBILITY OF MEDICAMENTS, PACKAGING FOR PRODUCING THE BUFFER SOLUTION AND KIT FOR TESTING CLINICAL STATES
#195Demarcation template for hazardous contaminant testing
#196Microfluidic platforms for drug discovery
#197THERAPEUTIC AGENT FOR FRONTOTEMPORAL LOBAR DEGENERATION, METHOD FOR SCREENING THERAPEUTIC AGENT FOR FRONTOTEMPORAL LOBAR DEGENERATION AND METHOD FOR TREATING FRONTOTEMPORAL LOBAR DEGENERATION
#198Method for measuring intracellular potential with a capacitance type potential measurement device
#199Modified Franz cell
#200ANTIMALARIAL DRUG, MALARIA TREATMENT METHOD, SCREENING METHOD FOR CANDIDATE SUBSTANCE FOR MALARIA TREATMENT, MALARIA SEVERITY MARKER, METHOD FOR TESTING RISK OF SEVERE MALARIA, AND TEST REAGENT
#201Time-of-flight physiological measurements and cloud services
#2023'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid and its salts formulation
#203Diagnostic drug and diagnostic method for Alzheimer's disease
#204METHOD FOR PRODUCING FUNCTIONALIZED NANOCRYSTALLINE CELLULOSE AND FUNCTIONALIZED NANOCRYSTALLINE CELLULOSE THEREBY PRODUCED
#205Oral Delivery System and Method
#206Polysorbate quantification assay
#207Capacitive biosensor for identifying a microorganism or determining antibiotic susceptibility
#208A CITY POLLUTION ENVIRONMENT SIMULATION APPARATUS
#209Time-of-flight imaging and physiological measurements
#210METHODS OF IDENTIFYING POTENTIAL COMPONENTS FOR TARGETED DRUG DELIVERY COMPOSITIONS
#211USE OF MAGNETIC RESONANCE SPECTROSCOPY TO CALIBRATE AND SELECT DOSES, FORMULATIONS, AND DEVICES FOR INTRA-NASAL ADMINISTRATION OF N-ACETYLCYSTEINE
#212METHOD AND APPARATUS FOR INDETIFICATION OF COUNTERFEIT DRUGS, PHARMACEUTICALS, OR MEDICINES
#213Method and apparatus for indetification of counterfeit drugs, pharmaceuticals, or medicines
#214Method for determining a concentration of a synthesis component in a radiopharmaceutical sample
#215METHOD FOR DETERMINING RELEASE RATES OF ACTIVE PRINCIPLE INGREDIENTS FROM AT LEAST ONE SEMISOLID FORM
#216COMPOSITIONS CONTAINING CANNABINOID ANALOG CONJUGATES AND METHODS OF USE
#217In vitro intestinal drug disposition device
#218SCREENING AND CONFIRMATION METHOD FOR VETERINARY DRUGS AND ADDITIVES IN ANIMAL-DERIVED FOOD
#219ABNORMAL CARDIAC RHYTHM MYOCARDIAL MODEL AND METHOD FOR PRODUCING SAME, AGENT FOR FORMING ABNORMAL CARDIAC RHYTHM MYOCARDIAL MODEL, AND METHOD FOR EVALUATING DRUG EFFICACY OF HEART DISEASE THERAPEUTIC
#220METHOD FOR PRODUCING LIBRARY FOR USE IN PREDICTION OF ACTION OF SUBSTANCE OF INTEREST ON LIVING BODY, AND METHOD FOR EVALUATING ACTION OF SUBSTANCE OF INTEREST ON LIVING BODY BASED ON CHANGE IN ACTION PARAMETER OR THE LIKE OF ZEBRAFISH
#221Quantitation of tamoxifen and metabolites thereof by mass spectrometry
#222Detection method for quality grade of traditional Chinese medicine
#223Method of determining radiation characteristic of a sample
#224Multiplexable super-resolution force spectroscopy using ultrasound methods and magnetic detection
#225Individualized solid dosage products and a system and method for the globally integrated pharmaceutical manufacturing and its monitoring thereof
#226Multi-wavelength wearable device for non-invasive blood measurements in tissue
#227Apparatus, buffer and method for pH control
#228ANGIOGENESIS INHIBITOR AND SCREENING METHOD FOR ANGIOGENESIS INHIBITORS
#229Saponin adjuvant and evaluation method thereof
#230APPARATUS AND METHOD FOR MEASURING DEGRADATION KINETICS OF A BIOMATERIAL IN AQUEOUS SOLUTION BELOW THE NORMAL FREEZING TEMPERATURE
#231SYSTEMS, DEVICES, AND METHODS FOR ULTRASONIC AGITATION MEDIATED KINETIC RELEASE TESTING OF COMPOUNDS
#232SYSTEMS AND METHODS FOR CHARACTERIZING SURFACTANT PROTEIN D (SP-D) OLIGOMERS
#233In situ, real-time in-line detection of filling errors in pharmaceutical product manufacturing using water proton NMR
#234Biopharmaceutical aggregation assessment and counterfeit detection using magnetic resonance relaxometry
#235ANALYSIS METHOD OF 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE BULK DRUG, TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSIS, INHIBITION OF PROGRESSION OF AMYOTROPHIC LATERAL SCLEROSIS, AND METHOD OF PRODUCING DRUG CONTAINING 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE BULK DRUG
#236Laser absorption spectroscopy isotopic gas analyzer
#237Continuous manufacturing system and method
#238Nontoxic compounds for use as taggants in nutritional and pharmaceutical products
#239AGING CONDITION EVALUATION METHOD, INFORMATION PRESENTATION METHOD, AND SCREENING METHOD FOR SUBSTANCE THAT IMPROVES OR PREVENTS AGING CONDITION
#240Methods for quantifying drug concentration in a prodrug composition
#241RPLC-based peptide mapping chromatographic performance using metal chelators as mobile phase additives
#242Method and device for determining a finished medicinal product
#243Liquid chromatographic method for the simultaneous analysis of antihypertensive and antilipidemic agents and interactions thereof
#244Method for observing sebaceous gland and use thereof
#245Method for evaluating protective effect against external damage to skin
#246The Use of Characteristic Electrochemical Signals for Fluid Identification
#247Method for Assessing Medicine
#248Method for inhibiting the expression of cancer-promoting factors
#249METHODS FOR PREDICTING CANCER DRUG RESPONSIVENESS
#250LIPOCALIN-TYPE PROSTAGLANDIN D2 SYNTHASE PRODUCTION PROMOTING AGENT
#251Non-invasive measurement of blood within the skin using array of laser diodes with Bragg reflectors and a camera system
#252Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#253Optical absorption spectroscopy based gas analyzer systems and methods
#254Method for determining sensitivity of cyclin-dependent kinase 4/6 inhibitor
#255PORTABLE MICROBIAL LOAD DETECTION
#256Rapid tumorigenicity screening system
#257Methods and compositions relating to chondrisomes from blood products
#258Methods and compositions relating to chondrisomes from cultured cells
#259Optical absorption spectroscopy based gas analyzer systems and methods
#260Genetic information analysis platform oncobox
#261System for non-invasive measurement using cameras and time of flight detection
#262PATCH DEVICES, METHODS AND APPARATUS FOR FORMING, AND TESTING PHARMACEUTICAL AGENT DELIVERY PATCH DEVICES
#263Time-of-flight measurement of skin or blood using array of laser diodes with Bragg reflectors
#264PHARMACEUTICAL MANUFACTURING INSTALLATION AND METHOD OF MANUFACTURING OF A PHARMACEUTICAL PRODUCT
#265Method and probe apparatus for testing pharmaceutical products
#266Devices and methods related to airway inflammation
#267Optical absorption spectroscopy based gas analyzer systems and methods
#268AGENT FOR PROMOTING MIGRATION OF PLURIPOTENT STEM CELLS
#269Componential analyzer, drug efficacy analyzer, and analysis method
#270USE OF TRYPTOPHAN DERIVATIVES FOR PROTEIN FORMULATIONS
#271CHARACTERIZATION AND APPLICATION OF POLYMERS FOR IN VIVO RELEVANT DRUG ABSORPTION CHARACTERIZATION IN VITRO
#272Use of a solid fraction sensor to evaluate a solid fraction of a target pharmaceutical sample and solid fraction sensor
#273Optical absorption spectroscopy based gas analyzer systems and methods
#274Method for evaluating immunogenicity of test substance
#275Optical absorption spectroscopy based gas analyzer systems and methods
#276Method for measuring alpha value of muscarinic M1 receptor positive allosteric modulators
#277Immunoassay-based determination of in-solution binding kinetics
#278Method for treating a chronic itch condition by administering small molecule MrgprX4 antagonists
#279Vial contents inspection and material identification method and apparatus
#280MARKERS FOR PHARMACEUTICALS
#281Unmasking endotoxins in solution
#282Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases
#283NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE
#284In situ determination of alum filling evenness and sedimentation in pharmaceutical products using water proton NMR
#285URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME
#286Ready to use porcine vaccine
#287Methods for validating medication
#288METHOD AND DEVICES FOR THE SPECTROPHOTOMETRIC DETERMINATION OF RESIDUAL PHASE TRANSFER CATALYST IN A PET RADIOPHARMACEUTICAL DOSE
#289Biopharmaceutical aggregation assessment and counterfeit detection using magnetic resonance relaxometry
#290Semiconductor source based near infrared measurement device with improved signal-to-noise ratio
#291DEVICE AND METHOD FOR DETERMINING AT LEAST ONE PHYSICAL PARAMETER OF PHARMACEUTICAL PRODUCTS
#292Devices With Optically Readable Liquid Reservoirs
#293Diffusion cells and related methods
#294Apparatus and method for humidity conditioning sample gas of a patient breathing circuit affiliated with a ventilator and/or nitric oxide delivery system
#295Pyridinone compound and use thereof
#296Abaloparatide formulations and methods of testing, storing, modifying, and using same
#297On-surface mass tagging
#298CANCER STEM CELL
#299Near-infrared time-of-flight imaging using laser diodes with Bragg reflectors
#300Stable production of virulent enterovirus 71 and use thereof